Actively Recruiting

All Genders
ID03299569

Establishing the Incidence of Tako-tsubo Cardiomyopathy in Scotland - the STARR Study

Led by University of Aberdeen · Updated on 2025-03-24

800

Participants Needed

1

Research Sites

N/A

Total Duration

On this page

Sponsors

U

University of Aberdeen

Lead Sponsor

N

NHS Tayside

Collaborating Sponsor

AI-Summary

What this Trial Is About

This research aims to understand Takotsubo cardiomyopathy, a condition that mimics a heart attack but occurs without blocked coronary arteries, often triggered by intense emotional or physical stress. The study seeks to identify all cases of Takotsubo cardiomyopathy in Scotland since 2010 and evaluate its frequency, causes, and health outcomes compared to heart attack patients and the general population. Public Health Scotland will collect data by identifying patients coded with relevant heart disease diagnoses and confirming Takotsubo cases through clinical records at participating health boards. The study includes a group of Takotsubo patients, a matched group from the general population, and a matched group of myocardial infarction patients for comparison. Data linkage will allow assessment of treatments, health events, and risks over more than a decade. Participants' medical records will be reviewed both retrospectively and going forward to track health outcomes, medication use, and survival rates. Researchers will focus on measuring mortality and morbidity over a 13-year period, including specific causes of these outcomes. This observational study does not involve treatment but collects important information to better understand Takotsubo cardiomyopathy and its impact on patients.

CONDITIONS

Brief Title

Establishing the Incidence of Tako-tsubo Cardiomyopathy in Scotland

Who Can Participate

All Genders

Eligibility Criteria

Eligible

You may qualify if you...

  • All patients diagnosed with Takotsubo cardiomyopathy
Not Eligible

You will not qualify if you...

History of severe allergic reactions to study medication Currently pregnant or breastfeeding Recent participation in another clinical trial within the last 30 days Presence of uncontrolled medical conditions that could affect safety

AI-Screening

AI-Powered Screening

Complete this quick 3-step screening to check your eligibility

1
2
3
+1

Your Study Journey

Screening

Duration - 2 to 4 weeks

Participants are screened for eligibility to participate in the trial.

Surveillance

Duration - Up to 13 years

Participants who have been diagnosed with Takotsubo cardiomyopathy or myocardial infarction are observed through electronic data linkage to assess outcomes, prescribing, and prediction scores.

Trial Site Locations

Total: 1 location

1

Cardiac Research Office

Aberdeen, Scotland, United Kingdom, AB25 2ZD

Actively Recruiting

Loading map...

Research Team

D

Dana Dawson, MD, MRCP

A

Amelia Rudd, HND

How is the study designed?

Study Type

OBSERVATIONAL

Masking

N/A

Allocation

N/A

Model

N/A

Primary Purpose

N/A

Number of Arms

2

Similar Trials

A Longitudinal Cohort of Patients With Acute Coronary Syndro...

Acute Coronary Syndrome

Actively Recruiting

1 location

Effects of Ziltivekimab Versus Placebo on Coronary Atheroscl...

Myocardial Infarction

Actively Recruiting

20 locations

AI-Enabled Direct-from-ECG Ejection Fraction (EF) Severity U...

Ventricular Ejection Fraction

Actively Recruiting

8 locations

Frequently Asked Questions

Have more questions? Get in touch with our team for quick support

Not the Right Trial for You?

Explore thousands of other clinical trials that might be a better match.
Sign up to get personalized trial recommendations delivered to your inbox.

Already have an account? Log in here

Published Research Related To This Trial

Slowly resolving global myocardial inflammation/oedema in Tako-Tsubo cardiomyopathy: evidence from T2-weighted cardiac MRI.

Christopher Neil, Thanh Ha Nguyen, Angela Kucia...

https://pubmed.ncbi.nlm.nih.gov/22791656

Stress hormone and circulating biomarker profile of apical ballooning syndrome (Takotsubo cardiomyopathy): insights into the clinical significance of B-type natriuretic peptide and troponin levels.

M Madhavan, B A Borlaug, A Lerman...

https://pubmed.ncbi.nlm.nih.gov/19468013

Pre-morbid psychiatric and cardiovascular diseases in apical ballooning syndrome (tako-tsubo/stress-induced cardiomyopathy): potential pre-disposing factors?

Matthew R Summers, Ryan J Lennon, Abhiram Prasad

https://pubmed.ncbi.nlm.nih.gov/20170799

Identification of risk loci with shared effects on five major psychiatric disorders: a genome-wide analysis.

Cross-Disorder Group of the Psychiatric Genomics Consortium

https://pubmed.ncbi.nlm.nih.gov/23453885